Sundia MediTech Company
Latest round
- Series B
Last raised
- Jan 2008
Total raised
- $2.4M
Investors
- 3
About Sundia MediTech Company
Sundia MediTech Company, Ltd.Founded in 2004 in Shanghai, China, Sundia MediTech Company, Ltd.Sundia MediTech offers a comprehensive suite of drug discovery and development services tailored for pharmaceutical and biotechnology companies. Their core offerings include Drug Substance and Drug Product development, Antibody-Drug Conjugates, Peptide Compound Management, and PROTAC solutions.Sundia MediTech generates revenue through project-based contracts and strategic partnerships within the pharmaceutical and biotechnology sectors. Their revenue model is based on long-term collaborations with milestone-based payments, including upfront fees tied to specific development milestones. The recent acquisition by BioDuro-Sundia aims to enhance its drug development services and explore new therapeutic areas. Furthermore, the company targets market expansion initiatives in the Asia-Pacific region, specifically looking to establish a stronger foothold in key biotech hubs by the end of 2023.
Who invested in Sundia MediTech Company
3 investors across 2 rounds
See all investors in Sundia MediTech Company
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sundia MediTech Company
Who invested in Sundia MediTech Company?
Sundia MediTech Company has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sundia MediTech Company raised?
Sundia MediTech Company has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sundia MediTech Company last raise money?
Sundia MediTech Company's most recent round on record is a Series B, in Jan 2008.
What does Sundia MediTech Company do?
Sundia MediTech Company is a pharmaceuticals company.
Where is Sundia MediTech Company headquartered?
Sundia MediTech Company is headquartered in Shanghai, China.
Which VCs invest in companies like Sundia MediTech Company?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Sundia MediTech Company's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Sundia MediTech Company? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.